Investigational New Drugs (INDs) and New Chemical Entities (NCEs) are related pharmaceutical industry concepts, however they differ in terms of drug development. NCEs contain unapproved active pharmaceutical ingredients (APIs) while INDs are developed drugs undergoing approval before clinical trials.